Aclaris Therapeutics, Inc. (ACRS) Social Stream



Aclaris Therapeutics, Inc. (ACRS): $6.56

0.09 (-1.35%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

ACLARIS THERAPEUTICS INC (ACRS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ACRS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-05-20 4 $50 $26 $34 $6.65 411.28%
2022-08-01 5 $50 $26 $34.8 $6.65 423.31%
2022-08-08 6 $50 $26 $34.8 $6.65 423.31%
2022-10-06 6 $50 $26 $34.333 $6.65 416.29%
2022-11-09 7 $50 $26 $34.333 $6.65 416.29%
2022-12-01 8 $50 $25 $33 $6.65 396.24%
2023-02-24 9 $50 $25 $32.5 $6.65 388.72%
2023-03-01 9 $50 $25 $33.5 $6.65 403.76%
2023-03-07 9 $43 $11 $30 $6.65 351.13%
2023-05-08 9 $43 $11 $29.125 $6.65 337.97%
2023-08-08 9 $43 $16 $29.375 $6.65 341.73%
2023-09-19 9 $43 $20 $29.875 $6.65 349.25%

The Trend in the Analyst Price Target


ACRS's average price target has moved down $4.46 over the prior 45 weeks.

ACRS reports an average of 183.7% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-14 9 50 25 32.500 16.17 100.99%
2023-02-24 9 50 25 32.500 12.07 169.26%
2023-02-24 9 50 25 32.875 12.07 172.37%
2023-03-01 9 50 25 33.500 12.24 173.69%
2023-03-09 9 43 11 29.125 7.66 280.22%

ACRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 9 0 0 0 0 9

The Trend in the Broker Recommendations


Over the past 21 months, ACRS's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ACRS has a greater upside potential (average analyst target price relative to current price) than 1367.44% of all US stocks.
  • In terms of how ACLARIS THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1096.24% of that group.
  • In the context of stocks in the small market cap category, ACLARIS THERAPEUTICS INC's number of analysts covering the stock is greater than 1230.6% of them.
  • In the context of stocks in the small market cap category, ACLARIS THERAPEUTICS INC's average analyst price target is higher than 1156.44% of them.

Stocks similar to ACLARIS THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are WVE, ALPN, and IMMP.

Is ACRS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!